These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19909734)

  • 1. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
    Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
    Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
    J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products in patients with decreased renal function.
    Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
    Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum sRAGE and esRAGE in women with normal pregnancy and preeclampsia.
    Kwon JH; Kim YH; Kwon JY; Park YW
    J Perinat Med; 2011 Sep; 39(5):507-13. PubMed ID: 21767223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
    Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
    Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
    Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
    Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia.
    Fukushima A; Kawahara H; Isurugi C; Syoji T; Oyama R; Sugiyama T; Horiuchi S
    J Obstet Gynaecol Res; 2005 Feb; 31(1):72-7. PubMed ID: 15669997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation.
    Kalousová M; Bartosová K; Zima T; Skibová J; Teplan V; Viklický O
    Kidney Blood Press Res; 2007; 30(1):31-7. PubMed ID: 17237617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response.
    Naruse K; Sado T; Noguchi T; Tsunemi T; Yoshida S; Akasaka J; Koike N; Oi H; Kobayashi H
    J Reprod Immunol; 2012 Mar; 93(2):69-74. PubMed ID: 22382005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth.
    Bastek JA; Brown AG; Foreman MN; McShea MA; Anglim LM; Adamczak JE; Elovitz MA
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1762-8. PubMed ID: 22339587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.